These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 16857816)
1. "Oncogenic shock": explaining oncogene addiction through differential signal attenuation. Sharma SV; Fischbach MA; Haber DA; Settleman J Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4392s-4395s. PubMed ID: 16857816 [TBL] [Abstract][Full Text] [Related]
2. Oncogene addiction: role of signal attenuation. Hübner A; Jaeschke A; Davis RJ Dev Cell; 2006 Dec; 11(6):752-4. PubMed ID: 17141149 [TBL] [Abstract][Full Text] [Related]
3. Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit? Felsher DW Cancer Res; 2008 May; 68(9):3081-6; discussion 3086. PubMed ID: 18451131 [TBL] [Abstract][Full Text] [Related]
4. Oncogene addiction. Weinstein IB; Joe A Cancer Res; 2008 May; 68(9):3077-80; discussion 3080. PubMed ID: 18451130 [TBL] [Abstract][Full Text] [Related]
5. A common signaling cascade may underlie "addiction" to the Src, BCR-ABL, and EGF receptor oncogenes. Sharma SV; Gajowniczek P; Way IP; Lee DY; Jiang J; Yuza Y; Classon M; Haber DA; Settleman J Cancer Cell; 2006 Nov; 10(5):425-35. PubMed ID: 17097564 [TBL] [Abstract][Full Text] [Related]
15. Can't kick that oncogene habit. Evan GI Cancer Cell; 2006 Nov; 10(5):345-7. PubMed ID: 17097554 [TBL] [Abstract][Full Text] [Related]
16. Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor. Bauer S; Yu LK; Demetri GD; Fletcher JA Cancer Res; 2006 Sep; 66(18):9153-61. PubMed ID: 16982758 [TBL] [Abstract][Full Text] [Related]
17. Drug development of MET inhibitors: targeting oncogene addiction and expedience. Comoglio PM; Giordano S; Trusolino L Nat Rev Drug Discov; 2008 Jun; 7(6):504-16. PubMed ID: 18511928 [TBL] [Abstract][Full Text] [Related]
18. Oncogene-dependent tumor suppression: using the dark side of the force for cancer therapy. Evan GI; Christophorou M; Lawlor EA; Ringshausen I; Prescott J; Dansen T; Finch A; Martins C; Murphy D Cold Spring Harb Symp Quant Biol; 2005; 70():263-73. PubMed ID: 16869762 [TBL] [Abstract][Full Text] [Related]
19. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors. Faivre S; Djelloul S; Raymond E Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796 [TBL] [Abstract][Full Text] [Related]
20. Requirement for Akt-mediated survival in cell transformation by the dbl oncogene. Morley S; Wagner J; Kauppinen K; Sherman M; Manor D Cell Signal; 2007 Jan; 19(1):211-8. PubMed ID: 16916597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]